SG11202011284RA - Non-human animal models of ditra disease and uses thereof - Google Patents

Non-human animal models of ditra disease and uses thereof

Info

Publication number
SG11202011284RA
SG11202011284RA SG11202011284RA SG11202011284RA SG11202011284RA SG 11202011284R A SG11202011284R A SG 11202011284RA SG 11202011284R A SG11202011284R A SG 11202011284RA SG 11202011284R A SG11202011284R A SG 11202011284RA SG 11202011284R A SG11202011284R A SG 11202011284RA
Authority
SG
Singapore
Prior art keywords
ditra
disease
animal models
human animal
models
Prior art date
Application number
SG11202011284RA
Inventor
Andrew Murphy
Alexander O Mujica
Ka-Man Venus Lai
Sokol Haxhinasto
Hovhannisyan Zaruhi
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of SG11202011284RA publication Critical patent/SG11202011284RA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/545—IL-1
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/15—Animals comprising multiple alterations of the genome, by transgenesis or homologous recombination, e.g. obtained by cross-breeding
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/035—Animal model for multifactorial diseases
    • A01K2267/0368—Animal model for inflammation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C12N2015/8527—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic for producing animal models, e.g. for tests or diseases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Environmental Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Husbandry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG11202011284RA 2018-07-16 2019-07-16 Non-human animal models of ditra disease and uses thereof SG11202011284RA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862698459P 2018-07-16 2018-07-16
US201962867477P 2019-06-27 2019-06-27
PCT/US2019/041964 WO2020018511A1 (en) 2018-07-16 2019-07-16 Non-human animal models of ditra disease and uses thereof

Publications (1)

Publication Number Publication Date
SG11202011284RA true SG11202011284RA (en) 2020-12-30

Family

ID=67544343

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202011284RA SG11202011284RA (en) 2018-07-16 2019-07-16 Non-human animal models of ditra disease and uses thereof

Country Status (9)

Country Link
US (2) US11589562B2 (en)
EP (1) EP3823443B1 (en)
JP (1) JP2021530970A (en)
KR (1) KR20210031868A (en)
CN (2) CN112638154B (en)
AU (1) AU2019308205A1 (en)
CA (1) CA3098040A1 (en)
SG (1) SG11202011284RA (en)
WO (1) WO2020018511A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7139419B2 (en) 2017-09-29 2022-09-20 リジェネロン・ファーマシューティカルズ・インコーポレイテッド Non-Human Animals Containing Humanized TTR Loci and Methods of Use
US11419318B2 (en) 2017-11-30 2022-08-23 Regeneran Pharmaceuticals, Inc. Genetically modified rat comprising a humanized TRKB locus
ES2966625T3 (en) 2019-04-04 2024-04-23 Regeneron Pharma Rodents comprising a humanized coagulation factor 12 locus
CA3137761A1 (en) 2019-06-04 2020-12-10 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized ttr locus with a beta-slip mutation and methods of use
EP3796776A1 (en) 2019-06-07 2021-03-31 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized albumin locus
KR20230038774A (en) * 2020-07-17 2023-03-21 베링거 인겔하임 인터내셔날 게엠베하 Anti-IL-36R antibody for treatment of neutrophilic dermatosis
WO2023072052A1 (en) * 2021-10-25 2023-05-04 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Genetically modified non-human animal with human or chimeric genes

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586251B2 (en) 2000-10-31 2003-07-01 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US20070160576A1 (en) 2001-06-05 2007-07-12 Genentech, Inc. IL-17A/F heterologous polypeptides and therapeutic uses thereof
CN101031316A (en) * 2004-07-29 2007-09-05 津莫吉尼蒂克斯公司 Use of il-28 and il-29 to treat cancer and autoimmune disorders
PT2767161T (en) 2004-10-19 2018-04-20 Regeneron Pharma Method for generating an non-human animal homozygous for a genetic modification
PT2769992T (en) * 2006-10-02 2021-03-11 Regeneron Pharma High affinity human antibodies to human il-4 receptor
RU2425880C2 (en) 2009-07-30 2011-08-10 Учреждение Российской академии наук Институт общей генетики им. Н.И. Вавилова РАН Method of producing transgene mice
PT3417701T (en) 2009-10-06 2022-03-16 Univ Yale Genetically modified mice and engraftment
FI3375284T3 (en) 2011-02-15 2023-06-15 Regeneron Pharma Humanized m-csf mice and uses thereof
BR112014009941B1 (en) 2011-10-28 2022-11-29 Regeneron Pharmaceuticals, Inc METHODS FOR PRODUCING A GENETICALLY MODIFIED RODENT EMBRYONIC STEM CELL(S)
SG11201400945UA (en) 2011-10-28 2014-04-28 Regeneron Pharma Humanized il-6 and il-6 receptor
ES2741649T3 (en) 2011-10-28 2020-02-11 Regeneron Pharma Mice with major genetically modified histocompatibility complex
HUE047437T2 (en) * 2011-11-16 2020-04-28 Boehringer Ingelheim Int Anti il-36r antibodies
US8962913B2 (en) 2012-06-18 2015-02-24 Regeneron Pharmaceuticals, Inc. Humanized IL-7 rodents
KR20240045263A (en) 2012-09-07 2024-04-05 예일 유니버시티 Genetically modified non-human animals and methods of use thereof
RU2673156C2 (en) 2012-11-05 2018-11-22 Ридженерон Фармасьютикалз, Инк. Genetically modified non-human animals and methods for use thereof
SG11201505968WA (en) 2013-02-20 2015-08-28 Regeneron Pharma Genetic modification of rats
EP3543253B1 (en) 2013-02-20 2024-03-27 Regeneron Pharmaceuticals, Inc. Mice expressing humanized t-cell co-receptors
US20150342163A1 (en) 2013-02-22 2015-12-03 Regeneron Pharmaceuticals, Inc. Genetically modified major histocompatibility complex mice
CN110192541B (en) 2013-02-22 2022-02-18 瑞泽恩制药公司 Mice expressing humanized major histocompatibility complex
SG11201508028QA (en) 2013-04-16 2015-10-29 Regeneron Pharma Targeted modification of rat genome
IL297607B2 (en) 2013-09-23 2024-01-01 Regeneron Pharma Non–human animals having a humanized signal–regulatory protein gene
RS55472B1 (en) 2013-10-15 2017-04-28 Regeneron Pharma Humanized il-15 animals
CA2929846C (en) 2013-11-19 2020-09-15 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized b-cell activating factor gene
EP3071025B1 (en) 2013-11-19 2018-10-10 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized a proliferation-inducing ligand gene
US9474255B2 (en) 2014-04-08 2016-10-25 Regeneron Pharmaceuticals, Inc. Non-human animals having humanized Fc-gamma receptors
WO2015171523A1 (en) 2014-05-05 2015-11-12 Regeneron Pharmaceuticals, Inc. Humanized c5 and c3 animals
NO2785538T3 (en) * 2014-05-07 2018-08-04
CN113045639A (en) 2014-05-19 2021-06-29 再生元制药公司 Genetically modified non-human animals expressing human EPO
IL287519B2 (en) 2014-06-19 2024-01-01 Regeneron Pharma Non-human animals having a humanized programmed cell death 1 gene
CN113016720B (en) 2014-11-24 2023-02-21 瑞泽恩制药公司 Non-human animals expressing humanized CD3 complexes
FI3850946T3 (en) 2014-12-05 2023-12-28 Regeneron Pharma Non-human animals having a humanized cluster of differentiation 47 gene
CN113412818B (en) 2014-12-09 2022-11-04 瑞泽恩制药公司 Non-human animal having humanized cluster of differentiation 274 gene
SI3280257T1 (en) 2015-04-06 2023-10-30 Regeneron Pharmaceuticals, Inc., Humanized t cell mediated immune responses in non-human animals
SG11201708380WA (en) 2015-04-13 2017-11-29 Regeneron Pharma Humanized sirpa-il15 knockin mice and methods of use thereof
BR112018010158A2 (en) 2015-11-20 2018-11-21 Regeneron Pharma rodent, humanized lag-3 polypeptide, cell or tissue, embryonic stem cell and rodent embryo, methods for producing a rodent to evaluate the antitumor efficacy and pharmacokinetic properties of a drug
EP3411392B1 (en) 2016-02-04 2021-12-29 Regeneron Pharmaceuticals, Inc. Non-human animals having an engineered angptl8 gene
ES2886958T3 (en) 2016-02-29 2021-12-21 Regeneron Pharma Rodents that have a humanized TMPRSS gene
SG11201907606XA (en) 2017-02-27 2019-09-27 Regeneron Pharma Humanized model of kidney and liver disorders
JP7139419B2 (en) 2017-09-29 2022-09-20 リジェネロン・ファーマシューティカルズ・インコーポレイテッド Non-Human Animals Containing Humanized TTR Loci and Methods of Use
US11419318B2 (en) 2017-11-30 2022-08-23 Regeneran Pharmaceuticals, Inc. Genetically modified rat comprising a humanized TRKB locus
US11576984B2 (en) 2018-03-26 2023-02-14 Regeneron Pharmaceuticals, Inc. Genetically modified mouse with humanized immunoglobulin heavy chain constant region genes and method of using

Also Published As

Publication number Publication date
US11589562B2 (en) 2023-02-28
CN112638154B (en) 2022-10-18
US20230172172A1 (en) 2023-06-08
JP2021530970A (en) 2021-11-18
KR20210031868A (en) 2021-03-23
CA3098040A1 (en) 2020-01-23
EP3823443A1 (en) 2021-05-26
US20200015462A1 (en) 2020-01-16
CN116200426A (en) 2023-06-02
CN112638154A (en) 2021-04-09
AU2019308205A1 (en) 2020-11-19
WO2020018511A1 (en) 2020-01-23
EP3823443B1 (en) 2024-05-22

Similar Documents

Publication Publication Date Title
SG11202011284RA (en) Non-human animal models of ditra disease and uses thereof
GB2561352B (en) Animal models and therapeutic molecules
LT3545326T (en) Automated noninvasive determining the sex of an embryo and the fertility of a bird`s egg
GB201816442D0 (en) Animal models and therapeutic molecules
IL255265A0 (en) Transgenice non-human animal expressing human-specific molecules and human fcg receptor family
IL279879A (en) Antibodies against disease causing agents of poultry and uses thereof
GB201622149D0 (en) Screenable liver disease models and methods
IL268621A (en) Non-human animal models of retinoschisis
GB201621639D0 (en) Leash training and a method of using the same to train a domesticated animal
NO20171353A1 (en) Improved closed fish farming tank
EP3505190A4 (en) Method for building model of animal suffering from non-human mammal obesity or related disease and use thereof
EP3877004C0 (en) Animal models and screening methods for intraocular disease or disorder
SG11201706054QA (en) Enterovirus 71 animal model
HK1242917A1 (en) Heterozygous modifications of tumor suppressor genes and swine model of neurofibromatosis type 1
IL252077A0 (en) Animal model for dry eye and methods of use of such animals
ZA201804136B (en) Repellent and attractant composition for dichromatic animals
GB201705535D0 (en) Animal model of neurodegenerative disease
GB201704983D0 (en) Animal model
DK3414999T3 (en) BREEDING FOR PIGS
CA186610S (en) Small animal habitat
CA186502S (en) Small animal habitat
CA186498S (en) Small animal habitat
CA185741S (en) Small animal habitat
CA185739S (en) Small animal habitat
CA185740S (en) Small animal habitat